voice search
Falcidoc-l Tablets

Falcidoc-l Tablets

Price:

Get Latest Price

In Stock

In Stock

Product Specifications

Product TypeMedical Tablets
Dominant ColorPink
Active IngredientsArtemether,Lumefantrine
Tablet Count60 tablets
PackagingBlister packs
Dosage FormTablets
UsageTreat malaria infections as per physician's prescription
StorageRoom temperature
FeaturesMalaria treatment, Effective dosage, Convenient packaging, High quality, Affordable price

Product Overview

Key Features

With our rich industry experience we are providing Falcidoc-L Tablets to our esteemed customers. The offered tablets are precisely formulated using high grade ingredients and advanced technology, our offered tablets can be obtained for us at marginal price.

Company Details

PHAMAZON OVERSEAS PVT. LTD., Established in 2017 at Mumbai in Maharashtra, is a leading Exporter,Manufacturer,Supplier of Pharmaceutical Ointments & Creams in India. PHAMAZON OVERSEAS PVT. LTD. is one of Trade India's verified and trusted sellers of listed products. With extensive experience in supplying and trading Falcidoc-L Tablets, PHAMAZON OVERSEAS PVT. LTD. has made a reputed name for itself in the market with high-quality Megalis, 400mg Sofosbuvir , ALCETAM 400MG TABLETS, etc.
Focusing on a customer-centric approach, PHAMAZON OVERSEAS PVT. LTD. has a pan-India presence and caters to a huge consumer base throughout the country. Buy Pharmaceutical Ointments & Creams in bulk from PHAMAZON OVERSEAS PVT. LTD. at Trade India quality-assured products.

Business Type

Exporter, Manufacturer, Supplier

Employee Count

18

Establishment

2017

Working Days

Monday To Saturday

GST NO

24AKTPS7898D1Z9

Payment Mode

Telegraphic Transfer (T/T)

Related Products

More Products From This Seller

Seller Details

GST

GST - 24AKTPS7898D1Z9

1 RatingRating

Mumbai, Maharashtra

Director

Mr Bhavesh Shah

Address

1/a Empress Business Bay, Near Uti Mutual Fund, Road No 11, Midc, Andheri East, Mumbai, Maharashtra, 400093, India

Pharmaceutical Ointments & Creams in Mumbai

Report incorrect details